Latest Arthur G. James Stories
The Alliance Shares the Latest Advances in the Center’s Treatment, Research and Educational Programs. PLAINSBORO, N.J.
DURHAM, N.C., April 10, 2015 /PRNewswire-iReach/ -- The Society for Translational Oncology (STO) is pleased to announce that Richard M.
This year's Fifth Annual Meeting of the Society for Translational Oncology (STO) is dedicated to the theme, "Perspectives on Progress: Using Genomics to Guide Clinical Therapy."
A new study has discovered how resistance develops in patients taking ibrutinib, a new and highly effective drug for the treatment of chronic lymphocytic leukemia (CLL).
The Ohio State University Comprehensive Cancer Center and Moffitt Cancer Center create ORIEN to accelerate more precise cancer treatments, diagnostics and prevention methods TAMPA,
Two clinical studies published in the New England Journal of Medicine with an accompanying editorial suggest that the novel agent ibrutinib shows real potential as a safe, effective, targeted treatment for adults with chronic lymphocytic leukemia (CLL) and for patients with mantle cell lymphoma (MCL).
A new, large-scale study of triple-negative breast cancer shows that small molecules called microRNA can be used to define four subtypes of this aggressive malignancy.
Doctors should use different therapies when treating older and younger patients with chronic lymphocytic leukemia.
Researchers have identified a prognostic marker in the most common form of chronic leukemia that can help to distinguish which patients should start treatment quickly from those who can safely delay treatment, perhaps for years.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.